Gemcitabine
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23814 publications
Gemcitabine and oxaliplatin with or without rituximab in relapsed or refractory post-transplant lymphoproliferative disorder following renal transplantation: a single centre experience.
Journal: Leukemia & lymphoma
Published: October 29, 2026
Dual-Targeted Agent Improves Advanced BTC Survival.
Journal: Cancer discovery
Published: October 27, 2026
Drug sensitivity analysis of monotherapy and combination therapy with Chinese and Western drugs in lung cancer organoid models
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: October 25, 2026
Combining DR5 activation with FGFR1 and VEGFR2 inhibition via an engineered TRAIL-based multimodal fusion protein for dual antitumor and antivascular activity in gastric and colorectal cancer models.
Journal: Journal of drug targeting
Published: October 22, 2026
Corrigendum to "Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer" [Redox Biol. 88 (2025) 103895].
Journal: Redox biology
Published: October 16, 2026
Real-World Comparative Effectiveness of Lobaplatin Versus Epirubicin and Gemcitabine for Post-TURBT Intravesical Therapy in Non-Muscle-Invasive Bladder Cancer.
Journal: Archivos espanoles de urologia
Published: October 15, 2026
Recent advances in systemic therapy for biliary tract cancer: Evidence from Japan and recommendations in guidelines.
Journal: Proceedings of the Japan Academy. Series B, Physical and biological sciences
Published: October 12, 2026
Suppression of RIPK3 by EZH2 contributes to cigarette smoking-induced chemoresistance in lung cancer.
Journal: bioRxiv : the preprint server for biology
Published: October 08, 2026
Blockade of mutant RAS oncogenic signaling: A 2026 update.
Journal: Pharmacological research
Published: October 06, 2026
Celastrol Sensitizes Bladder Cancer to Gemcitabine by Regulating LINC00839-Mediated Homologous Recombination DNA Repair.
Journal: Biochemistry. Biokhimiia
Published: October 04, 2026
Presentation and management of tislelizumab induced toxic optic neuropathy.
Journal: BMJ case reports
Published: October 01, 2026
Last Updated: 11/08/2026